Eton Pharmaceuticals ETON
NASDAQ ETON
$67.54 +3.19 (+4.96%)
At close: Nov 10, 2026 · 4:00 PM EST

Eton Pharmaceuticals (ETON) Preferred Stock Liabilities (2017 - 2018)

Updated

Eton Pharmaceuticals (ETON) reported Preferred Stock Liabilities of $21.16 million for Q3 2018.

Analysis

Eton Pharmaceuticals (ETON) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends

At the end of FY2017, Eton Pharmaceuticals posted Preferred Stock Liabilities of $19 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Eton Pharmaceuticals 1.95 Bn 1.82 Bn 44.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 21.16 Mn
Dec 31, 2017 19.00 Mn
API Access

Eton Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ETON&period=max&api_key=YOUR_API_KEY